Browse studies

Find your next paid study

1 recruiting study matching your filters

A Pilot Clinical Trial of Motixafortide for Measurable Residual Disease (MRD) Sensitization in Acute Myeloid Leukemia (AML)

This is a pilot phase I study evaluating the effect of motixafortide on determination of measurable residual disease (MRD) level in patients with acute myeloid…

Acute Myeloid LeukemiaMeasurable Residual Disease

Washington University School of MedicineNCT07392970